The investigational monoclonal antibody cendakimab significantly improved symptoms and reduced esophageal eosinophils in patients with eosinophilic esophagitis at 24 weeks, a randomized phase III ...

For initial treatment of eosinophilic esophagitis (EoE), an elimination diet is the most cost-effective option from a payer perspective and proton pump inhibitor (PPI) therapy is more cost-effective ...

Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis ...

Please provide your email address to receive an email when new articles are posted on . The impact of food elimination diets on medication previously was unknown. Absolute mean changes in Dysphagia ...

At week 12, the highest dosed patients achieved the best tissue response seen in the trial to date, with a near complete ...